Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q in pediatric ADHD
NCT04216186Phase 3Recruiting
- Start
- Nov 2018
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of coenzyme q10 in attention deficit hyperactivity disorder (ADHD). Started Nov 2018; status: recruiting.
02
Drugs
coenzyme q10
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04216186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216186.